Clinical Trials Directory

Trials / Completed

CompletedNCT04143334

Prevalence of Blindness, Visual Impairment in Chao Nan Area, China

Prevalence of Blindness, Visual Impairment and Main Avoidable Causes in Chao Nan Area

Status
Completed
Phase
Study type
Observational
Enrollment
3,700 (actual)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers

Summary

This study will provide a profile of blindness/visual impairment, avoidable blindness and cataract surgery service in Chaonan, mainland China. We also evaluate the diagnostic accuracy of Rapid Assessment of Avoidable Blindness (RAAB) comparison with conventional survey.

Detailed description

This proposal describes a population-based study aimed at determining the prevalence of visual impairment, blindness and major causes in adults age 50 years old and above in Chaonan County of Guangdong province, where one of the Project Vision Charity Eye center was founded in 2009. In the proposed study, we will examine 3700 Chaonan County residents aged 50 years and older, selected via a clustered, randomized sampling with probability proportional to size (PPS). The cluster will be at the village level, 50 subjects aged 50 years and older will be examined in each cluster includes Visual acuity, torch light, and fundus review, the major cause of blindness or visual impairment will be determined. We also randomly recruited 60% clusters,total 2250 participants, from RAAB survey to conduct a detailed conventional eye examination. This study will provide a profile of blindness/visual impairment, avoidable blindness and cataract surgery service in Chaonan. we will evaluate the diagnostic accuracy of Rapid Assessment of Avoidable Blindness (RAAB) comparison with conventional survey. . It will provide important public health issues for the purposes of establishing a sustainable and suitable model to eliminate the cataract blindness in China.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTConventional survey

Timeline

Start date
2012-04-01
Primary completion
2015-12-01
Completion
2016-12-01
First posted
2019-10-29
Last updated
2019-10-31

Source: ClinicalTrials.gov record NCT04143334. Inclusion in this directory is not an endorsement.